PharmaClik Login 
Pharmacists are highly trained healthcare professionals who play a vital role in the management of patients' health, including the prescribing of medications. Pharmacist prescribing authority – their ability to prescribe medications, initiate and adjust doses, and manage drug therapeutic substitutions for patients without the need for physician involvement – has been an ongoing topic of policy discussions across all Canadian provinces in the aftermath of the COVID-19 pandemic. Expanding prescribing authority to pharmacists’ full capabilities across all provinces has never been more urgent and relevant than in this period of severe, enduring healthcare professional shortage across the country.
Princess Margaret Cancer Centre and McKesson Canada partner to elevate best practices for cancer treatment in community infusion clinics - McKesson Canada
McKesson Canada’s Newsroom
Discover the latest in healthcare and headlines about McKesson Canada.
McKesson Canada’s Newsroom
Discover the latest in healthcare and headlines about McKesson Canada.
Press Releases
Princess Margaret Cancer Centre and McKesson Canada partner to elevate best practices for cancer treatment in community infusion clinics
Toronto, ON (October 24, 2024) – Princess Margaret Cancer Centre, part of University Health Network in Toronto, has partnered with McKesson Canada to implement best practices for the delivery of high-quality care to cancer patients who receive treatment in the organization’s network of community infusion clinics.
As part of their cancer journey, some oncology patients use independent, community-based infusion clinics, which can offer a wider variety of treatment options for patients and provide access to leading edge medicines. This partnership will benefit patients and ensure they receive the same level of seamless, high-quality care at McKesson Canada’s INVIVA clinics as they do at Princess Margaret.
To date, formal relationships between community infusion clinics and cancer centres have been limited. Before launching the partnership, Princess Margaret conducted a comprehensive inspection of McKesson Canada’s oncology services, which are accredited by Accreditation Canada, including its infusion clinics and pharmacy at its central Toronto location. With the partnership now in place, Princess Margaret and McKesson Canada look forward to working together to align quality standards.
About Princess Margaret Cancer Centre
The Princess Margaret Cancer Centre has gained an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is part of University Health Network in Toronto. For more information: www.theprincessmargaret.ca
About McKesson Canada
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.
For media inquiries:
The Princess Margaret Cancer Centre
Marina Jimenez
McKesson Canada
Sybil Millar
A significant public policy priority for the Government of Canada is ensuring comprehensive, timely, and equitable access to medication for rare diseases; as such, the Government of Canada has allocated $500 million annually to a national strategy for rare disease drugs. McKesson Canada is proud to contribute to this conversation, drawing on experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services.
During the COVID-19 pandemic in Canada, it became clear that any return to 'normal' would only be possible once the majority of Canadians received vaccines. At the time, a COVID-19 vaccine existed only in the designs of biomedical scientists, and most did not anticipate a mass-market vaccine arriving for at least 18 months. In addition to developing the vaccine, the pharmaceutical sector had to conquer the challenge of manufacturing, transporting, storing, and administering billions of doses.
Connect with McKesson Canada
LinkedIn | Facebook | X (Twitter) | Instagram
For all media inquiries, please contact media@mckesson.ca
